Displaying 1 - 1 of 1
| Active Ingredient | METAMIZOL |
| Therapeutic Class | ANALGESICS AND PYRETICS MISCELLANEOUS |
| Indications | Dengue fever where no alternative is available or suitable. |
| Caution | Administration is associated withincreased risk of agranulocytosis, anaphylactic shock. Severe cutaneous reactions, bronchospasm. |
| Dose Range |
Tabs: 500mg-4g daily in divided doses. Drops: 0.1-0.5 ml daily . See BDS supply protocols pg. 4. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |